How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP-Reference-Cited by-同舟云学术

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

Published:2018-10 Issue:4 Volume:4 Page:215-224
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Pilkington Victoria,Hill Andrew,Hughes Sophie,Nwokolo Nneka,Pozniak Anton

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference70 articles.

1. UNAIDS. UNAIDS Data 2017. Available from:www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf (accessed May 2018).

2. RGranich, SCrowley, MVitoriaet al.Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opinion HIV AIDS.

3. ARodger, VCambiano, TBruunet al.Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: the PARTNER2 study extended results in gay men. AIDS 2018. July 2018. Amsterdam, Netherlands. Abstract WEAX0104LB.

4. BBavinton, BGrinsztejn, NPhanuphak, FJin. HIV treatment prevents HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil. IAS 2017. July 2017, Paris, France. Abstract 5469.

5. World Health Organization. HIV/AIDS programme guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Available athttp://apps.who.int/iris/bitstream/handle/10665/75188/9789241503884_eng.pdf?sequence=1 (accessed May 2018).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?;Clinical Infectious Diseases;2024-04-12

2. How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities?;Annals of Internal Medicine;2024-04

3. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential;Expert Review of Anti-infective Therapy;2024-03-27

4. Barriers to the uptake of oral pre-exposure prophylaxis among young key populations in Nigeria;International Journal of STD & AIDS;2023-12-17

5. Preventive and Sexual Health in LGBTQ+ Older Adults;Clinics in Geriatric Medicine;2023-11